Similar articles

• Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.

  Rickels K, Csanalosi I, Werblowsky J, Weise CC, Weinstock R, Brown AS, Winokur A, Von Poelnitz M. Rickels K, et al. J Clin Psychiatry. 1982 Oct;43(10):419-22. J Clin Psychiatry. 1982. PMID: 6749826 Clinical Trial.
• [Double-blind comparative study of alprazolam (Xanax) and amitriptyline in the treatment of anxiety associated with depression].

  Bernardi F, Cairoli S, D'Aurizio C, De Rosa A, Grasso A, Sannino V, Savoldi F, Sorge F, Casadei GL. Bernardi F, et al. Minerva Psichiatr. 1988 Oct-Dec;29(4):203-10. Minerva Psichiatr. 1988. PMID: 3074234 Clinical Trial. Italian. No abstract available.
• The pharmacological treatment of delusional depression.

  Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Neil JF, Perel JM, Rossi AJ, Soloff PH. Spiker DG, et al. Am J Psychiatry. 1985 Apr;142(4):430-6. doi: 10.1176/ajp.142.4.430. Am J Psychiatry. 1985. PMID: 3883815 Clinical Trial.
• Anxiety associated with comorbid depression.

  Möller HJ. Möller HJ. J Clin Psychiatry. 2002;63 Suppl 14:22-6. J Clin Psychiatry. 2002. PMID: 12562115 Review.
• Use of atypical antipsychotics in refractory depression and anxiety.

  Nemeroff CB. Nemeroff CB. J Clin Psychiatry. 2005;66 Suppl 8:13-21. J Clin Psychiatry. 2005. PMID: 16336032 Review.